Heart Tumor Market Size Worth USD 1.36 Billion by 2030 at

New York, USA, Sept. 29, 2022 (GLOBE NEWSWIRE) — Heart Tumor Market Overview

According to a Comprehensive Research Report by Market Research Future (MRFR), “Heart Tumor Market Information By Tumor Type, Diagnosis & Treatment, And Region – Forecast till 2030″; the market will reach USD 1,367 Million by 2030, an 8.5% CAGR.

Heart Tumor Market Synopsis

A cardiac tumor is an abnormal enlargement of the heart tissue, which can be either malignant or not. Heart tumors, also known as cardiac tumors, are uncommon abnormal growths that appear in the heart. Heart tumors can develop anywhere, including on the heart’s valves, inside the heart muscle, within a chamber, or even outside the chest. Most pediatric cardiac tumors are benign, which means they are not cancerous and are not likely to spread to other organs. However, even benign growths risk life if they impair blood flow or result in an irregular heartbeat. Primary cardiac tumors are incredibly rare. Primary cardiac tumors start in the heart and can be malignant or not.

When cancer from another part of the body travels to the heart, it causes metastatic heart tumors. Secondary cardiac tumors are 20–30 times more probable than primary cardiac tumors to form in persons with lung cancer, renal cell carcinoma, breast cancer, melanoma, or lymphoma. Heart tumors can be of different sizes and shapes. Some grow on a stalk and are pedunculated. Heart tumors can range in size from less than one centimeter in diameter to 15 centimeters in diameter. The symptoms and need for therapy are impacted by their size and placement within your heart.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/5065

Report Scope: